Once viewed only as power generators, mitochondria are now understood to play a role in mental illness. Their ability to ...
Stocktwits on MSN
ANRO stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point
H.C. Wainwright said the failure of ALTO-101 in its Phase 2 study does not change its overall view on Alto Neuroscience. ・Baird cut Alto’s price target to $38 from $41 but said the company’s ...
I remember the first time I heard the time "treatment resistant." It was from a friend as they shared with me their mental health story. As this conversation took place some years before my schooling ...
LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S.NOVA-2 trial to enroll approximately 460 patientsPrimary ...
Hosted on MSN
Scientists link immune system proteins to mental health conditions like schizophrenia and depression
New research suggests that immune system activity may play a role in the development of several major mental health conditions. The study, published inMolecular Psychiatry, identified 29 ...
Shebani Sethi is at the vanguard of metabolic psychiatry, a field that investigates the link between diet and serious mental ...
Stress in the teen years may have long-term effects on brain function, increasing the risk of mental health disorders later ...
New research bolsters the idea that the risk for psychiatric and developmental disorders isn’t specific to particular conditions — and that could mean new opportunities to treat mental illnesses that ...
Caplyta may start working after a week of treatment. However, you may not notice a change in your symptoms for a few weeks. Symptoms of schizophrenia may include psychosis (altered perception of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results